Results 21 to 30 of about 989,554 (310)

Treatment of immunoglobulin-resistant kawasaki disease: a Bayesian network meta-analysis of different regimens

open access: yesFrontiers in Pediatrics, 2023
BackgroundThis study aimed to gather evidence from clinical trials on the efficacy and safety of the available treatments for intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD) in children.MethodsThis work adopted the Newcastle–Ottawa ...
Yan Pan, Qihong Fan, Luoyi Hu
doaj   +1 more source

Subcutaneous Immunoglobulin-G Replacement Therapy with Preparations Currently Available in the United States for Intravenous or Intramuscular Use: Reasons and Regimens

open access: yesAllergy, Asthma & Clinical Immunology, 2005
For patients who require replacement therapy for primary immunodeficiency, subcutaneous infusions of immunoglobulin G (IgG) may be preferable to intravenous infusions for several reasons.
Chouksey Akhilesh   +3 more
doaj   +1 more source

Control Volume Analysis of the Infusion Rate in Cephalic and Median Cubital Veins Based on Infusion Bag Height and Peripheral Venous Catheter Inner Diameter: Application of Bernoulli’s Equation and Consideration of Frictional Forces

open access: yesJournal of Multidisciplinary Healthcare, 2023
Jeongwon Han,1 Hanna Lee2 1College of Nursing Science, Kyung Hee University, Seoul, Republic of Korea; 2Department of Nursing, Gangneung-Wonju National University, Gangwon‑do, Republic of KoreaCorrespondence: Hanna Lee, Department of Nursing, Gangneung ...
Han J, Lee H
doaj  

Guidelines for the safe practice of total intravenous anaesthesia (TIVA)

open access: yesAnaesthesia, 2018
Guidelines are presented for safe practice in the use of intravenous drug infusions for general anaesthesia. When maintenance of general anaesthesia is by intravenous infusion, this is referred to as total intravenous anaesthesia.
A. Nimmo   +10 more
semanticscholar   +1 more source

Y-site compatibility of intravenous medications commonly used in intensive care units: laboratory tests on 75 mixtures involving nine main drugs

open access: yesPharmaceutical Technology in Hospital Pharmacy, 2022
Patients hospitalized in intensive care units often require multiple drug infusions. Due to limited intravenous accesses, concomitant administration of drugs in the same infusion line is often necessary. Compatibility studies of Y-site administration are
Ayari Gillian   +3 more
doaj   +1 more source

Determination of ifenprodil by LC–MS/MS and its application to a pharmacokinetic study in healthy Chinese volunteers

open access: yesActa Pharmaceutica Sinica B, 2013
This paper reports the development and validation of an assay for ifenprodil based on liquid chromatography–tandem mass spectrometry (LC–MS/MS) and its application to a pharmacokinetic study involving single and multiple intravenous infusions to healthy ...
Jing Yang   +9 more
doaj   +1 more source

Immediate adverse reactions to intravenous immunoglobulin in primary immune deficiencies: a single center experience

open access: yesThe Turkish Journal of Pediatrics, 2020
Background and Objective. Adverse reactions related to intravenous immunoglobulin (IVIG) infusions vary from 1 to 81%, with an average of 20%. They may be classified as immediate; occurring during the infusion itself or delayed; occurring after ...
Ercan Nain   +5 more
doaj   +1 more source

Effect of Serial Infusions of CER-001, a Pre-&bgr; High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial

open access: yesJAMA cardiology, 2018
Importance CER-001 is a negatively charged, engineered pre-&bgr; high-density lipoprotein (HDL) mimetic containing apolipoprotein A-I and sphingomyelin.
S. Nicholls   +17 more
semanticscholar   +1 more source

Case report: Dendritic cell-cytokine induced killer cell therapy in subjects with chronic lymphocytic leukemia and peritoneal cancer

open access: yesFrontiers in Medicine, 2023
This study aimed to characterize the safety and efficacy of DC-CIK therapy in two patients with previously treated chronic lymphocytic leukemia or peritoneal cancer, respectively.
Brian Mehling   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy